Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8029782 Therapeutic ribonucleases

Patent 8029782 was granted and assigned to Quintessence Biosciences on October, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Quintessence Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8029782

Patent Inventor Names

Laura Strong0

John Kink0

Tony Klink0

Date of Patent

October 4, 2011

Patent Application Number

12572016

Date Filed

October 1, 2009

Patent Citations Received

‌

US Patent 12077790 Optimized binuclease fusions and methods

‌

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

Patent Primary Examiner

‌

Tekchand Saidha

Patent abstract

The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8029782 Therapeutic ribonucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API